Literature DB >> 15193598

ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.

Riccardo Della Nave1, Silvia Foresti, Carlo Tessa, Marco Moretti, Andrea Ginestroni, Cinzia Gavazzi, Laura Guerrini, Fabrizio Salvi, Silvia Piacentini, Mario Mascalchi.   

Abstract

Analysis of the apparent diffusion coefficient (ADC) maps derived from diffusion-weighted MR imaging is emerging as a reproducible, sensitive, and quantitative tool to evaluate brain damage in diseases of the white and gray matter. To explore the potentials of ADC maps analysis in degenerative ataxias, we examined 28 patients and 26 age-matched controls with T1, T2, and diffusion (b values 0-1000 along the three main body axes)-weighted MR images. Twenty-four patients had inherited genetically proven diseases including spinocerebellar ataxia type 1 (SCA1) (n = 9), spinocerebellar ataxia type 2 (SCA2) (n = 8), and Friedreich's ataxia (FA) (n = 7), whereas four patients had sporadic adult onset pure cerebellar ataxia (three idiopathic, one gluten intolerance). Area and linear measurements of the CNS structures contained in the posterior cranial fossa (PCF) preliminary enabled classification of the patients in the three morphological categories reflecting the gross pathology findings, namely olivopontocerebellar atrophy (OPCA) (n = 10: six SCA2 and four SCA1), spinal atrophy (SA) (n = 7: all FA), and cortical cerebellar atrophy (CCA) (n = 4: three idiopathic and one gluten intolerance). Seven patients with SCA1 (n = 5) or SCA2 (n = 2) had morphologic changes reminiscent of OPCA, but their values were still in the lower normal range and were classified as undefined. Mean diffusivity (D) maps of the entire brain were generated and D was measured with regions of interest (ROI) in the medulla, pons, middle cerebellar peduncles, and the peridentate white matter. Moreover, after exclusion of the skull with manual segmentation and of the CSF with application of a threshold value, histograms were obtained for D of the brainstem and cerebellum and for D of the cerebral hemispheres. As compared to controls, a (P < 0.001) increase of D was observed in the medulla, middle cerebellar peduncles, and peridentate white matter in OPCA and undefined patients groups who had also significantly increased values of the 25th and 50th percentiles in the brainstem and cerebellum D histogram. In CCA (P = 0.01), an increase of the 25th and 50th percentile of the D value was observed in the brainstem and cerebellum histograms. The SA group showed (P < 0.001) an increased D in the medulla only. A correlation between clinical severity as assessed with the Inherited Ataxias Clinical Rating Scale (IACRS) and the 50th percentile of the D value in the brainstem and cerebellum histogram (r = 0.69) was observed in patients with SCA1 or SCA2. Diffusion MR imaging reveals variable patterns of increase of D in the brainstem, cerebellum, and cerebral hemispheres in degenerative ataxias that match the known distribution of the neuropathological changes.

Entities:  

Mesh:

Year:  2004        PMID: 15193598     DOI: 10.1016/j.neuroimage.2004.01.035

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  13 in total

Review 1.  Spinocerebellar ataxias.

Authors:  Mario Mascalchi
Journal:  Neurol Sci       Date:  2008-10       Impact factor: 3.307

2.  Impact of cerebellar atrophy on cortical gray matter and cerebellar peduncles as assessed by voxel-based morphometry and high angular resolution diffusion imaging.

Authors:  Michael Dayan; G Olivito; M Molinari; Mara Cercignani; Marco Bozzali; M Leggio
Journal:  Funct Neurol       Date:  2016 Oct/Dec

3.  Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms.

Authors:  Zora Kikinis; Kang Ik K Cho; Ioana L Coman; Petya D Radoeva; Sylvain Bouix; Yingying Tang; Ryan Eckbo; Nikos Makris; Jun Soo Kwon; Marek Kubicki; Kevin M Antshel; Wanda Fremont; Martha E Shenton; Wendy R Kates
Journal:  Brain Imaging Behav       Date:  2017-10       Impact factor: 3.978

Review 4.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

5.  Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters.

Authors:  Zhaowei Meng; Guizhi Zhang; Haoran Sun; Jian Tan; Chunshun Yu; Weijun Tian; Weidong Li; Zhiqiang Yang; Mei Zhu; Qing He; Yujie Zhang; Shugao Han
Journal:  Exp Ther Med       Date:  2015-04-17       Impact factor: 2.447

6.  Loss of intrinsic organization of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease severity and duration.

Authors:  Ana Solodkin; Eitan Peri; E Elinor Chen; Eshel Ben-Jacob; Christopher M Gomez
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

7.  (1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2.

Authors:  Isabelle Iltis; Diane Hutter; Khalaf O Bushara; H Brent Clark; Myron Gross; Lynn E Eberly; Christopher M Gomez; Gülin Oz
Journal:  Brain Res       Date:  2010-08-14       Impact factor: 3.252

8.  Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2.

Authors:  M L Mandelli; T De Simone; L Minati; M G Bruzzone; C Mariotti; R Fancellu; M Savoiardo; M Grisoli
Journal:  AJNR Am J Neuroradiol       Date:  2007 Nov-Dec       Impact factor: 3.825

9.  Diffusion tensor imaging of the cortico-ponto-cerebellar pathway in patients with adult-onset ataxic neurodegenerative disease.

Authors:  Kaeko Kitamura; Keiko Nakayama; Satoru Kosaka; Eiji Yamada; Hiroyuki Shimada; Takami Miki; Yuichi Inoue
Journal:  Neuroradiology       Date:  2008-01-03       Impact factor: 2.804

10.  A whole-brain analysis in de novo Parkinson disease.

Authors:  C Tessa; M Giannelli; R Della Nave; C Lucetti; C Berti; A Ginestroni; U Bonuccelli; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.